The #1 prescribed novel oral
anticoagulant in the US*1
The patients they studied are the ones I see.
AMONG NOVEL ORAL ANTICOAGULANTS:
Most real-world experience: more than 2 million patients prescribed
in the US.2
Most safety data generated in clinical trials in patients
studied with high risk of thrombotic events.†3-16
Most affordable: the lowest average
out-of-pocket cost.17
Not intended to be a comparison of safety
or efficacy outcomes.
*Among Factor Xa inhibitors and direct th